It is estimated that in 2009 85 percent of all radical prostatectomies performed robots.

It is estimated that in 2009 85 percent of all radical prostatectomies performed robots. This approach has become the standard of care in many urological communities across the country, but in the first years of the laparoscopic choleceptectomy missing the robot guidelines for the training and safe use of this new technology into clinical practice.. Training, credentialing, monitoring data and Medicolegal risks of robotic urological surgery: recommendations of the Society of Urologic Robotic – The rapid application of laparoscopic and robotic surgery for radical prostatectomy for prostate cancer has really mirrored that of laparoscopic cholecystectomy in the early 1990s.

Therefore, it seems necessary for us surgeons adequately train surgeons and on the technical aspects of the equipment they As such, the their clinical practice. As such, the AUA Basic Robotic Skills Guidelines is the basic technical knowledge and skills needed to address to make effective and safe robot assisted surgery be performed, and are likely to site on the AUA in 2010.Joseph V. President and CEO, MELA Sciences, said: The FDA approvable letter received for MelaFind is a momentous milestone for MELA Sciences and millions of Americans a higher risk at increased risk to melanoma, most deadly form of skin cancers the company make an objective to provide an objective tool to dermatologist realize melanoma his earliest of developing, most treatable step.

MelaFind is a utility for the evaluation of clinically atypical cutaneous lesions pigmeted where a dermatologist to an additional data before it want to be excluded the final decision to biopsy collect melanoma. Says that says that MelaFind be a non – invasive and objective multi-spectral machine system as a tool for dermatologist in the recognition of earlier, melanoma designed to to help. .